|
|
 |
|
News
| Jan 6, 2010 | American Regent, Inc. announces the availability of Metoprolol Tartrate Injection, USP |
| Jan 6, 2010 | Luitpold Pharmaceuticals, Inc. Acquires PharmaForce, Inc. a U.S. Specialty Injectable Pharmaceutical Company |
| Nov 3, 2009 | American Regent expands voluntary recall of Ketorolac Tromethamine Injection, USP |
| Oct 20, 2009 | American Regent voluntarily recalls Ketorolac Tromethamine Injection, USP |
| Sep 23, 2009 | Dexferrum Important Drug Warning and Important Safety Information |
| Sep 16, 2008 | Luitpold Pharmaceuticals/American Regent announces closing of exclusive sublicense of Venofer® by Fresenius Medical Care in U.S. |
| Jul 9, 2008 | Luitpold Pharmaceuticals/American Regent and Fresenius Medical Care sign agreements for exclusive sublicense of Venofer® in U.S. |
| Mar 12, 2008 | Luitpold Pharmaceuticals INJECTAFER™ (ferric carboxymaltose injection) receives non-approvable letter from FDA |
| Feb 5, 2008 | FDA Advisory Panel Supports Favorable Risk-Benefit Profile for Injectafer™ Under Certain Indications |
| Dec 18, 2007 | Osteohealth Company to Aquire Dental Therapeutics Business |
| Dec 20, 2005 | Osteohealth Company Announces FDA Approval of GEM 21S® Growth-factor Enhanced Matrix for the Treatment of Periodontally-related Bone Defects |
| Oct 17, 2005 | Venofer® receives FDA Approval for the treatment of Iron Deficiency Anemia in Peritoneal Dialysis Patients |
| Jun 17, 2005 | Venofer® receives FDA approval for the Treatment of Iron Deficiency Anemia in CKD |
| Mar 29, 2005 | American Regent launches Calcitriol Injection |
| Nov 19, 2004 | BioMimetic Pharmaceuticals Receives Approvable Recommendation from FDA Advisory Panel for GEM 21S™ |
| Oct 29, 2003 | Luitpold Pharmaceuticals, Inc. Acquires Drug Targeting Technology And Targaceutical® Drug Candidates |
|
|
|
